ArticleMolecular biology reports2026

Next-generation CD179a-CAR-T cells demonstrate potent and sustained anti-tumor activity in preclinical B-cell malignancies.

Hoda Mohamed Elessawey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.